These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22300776)

  • 1. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee.
    Stevenson WG; Hernandez AF; Carson PE; Fang JC; Katz SD; Spertus JA; Sweitzer NK; Tang WH; Albert NM; Butler J; Westlake Canary CA; Collins SP; Colvin-Adams M; Ezekowitz JA; Givertz MM; Hershberger RE; Rogers JG; Teerlink JR; Walsh MN; Stough WG; Starling RC;
    J Card Fail; 2012 Feb; 18(2):94-106. PubMed ID: 22300776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure: what proportion of patients satisfy the electrocardiographic criteria for cardiac resynchronization therapy?
    Gupta SN; Jose VJ; Chandy ST
    Indian Heart J; 2003; 55(6):619-23. PubMed ID: 14989512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
    Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
    Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy in patients with a narrow QRS complex.
    Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding cardiac resynchronization for systolic heart failure to patients with mechanical dyssynchrony and atrial fibrillation.
    Ghanbari H; Hassunizadeh B; Machado C
    Rev Cardiovasc Med; 2005; 6(3):140-51. PubMed ID: 16195687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York heart association class II, and narrow QRS heart failure patients.
    Wein S; Voskoboinik A; Wein L; Billah B; Krum H
    J Card Fail; 2010 May; 16(5):432-8. PubMed ID: 20447580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in cardiac resynchronization therapy.
    Steffel J; Holzmeister J; Abraham WT
    Postgrad Med; 2011 Mar; 123(2):18-26. PubMed ID: 21474889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.